Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Emerging Giants: AI-Driven Innovators Under $2 Set to Transform Markets INBS, PRSO, LPSN, PACB, NINE
August 08, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
INBS
PRSO
Why Choose Capsule Tablet Metal Detector in Pharmaceutical Industry?
August 08, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease
August 08, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVS
JD.JUNE’s Bodysuits for Bosses: Revolutionizes Corporate America
August 08, 2024
Via
Syndication Cloud
Topics
Product Recall
Exposures
Legal
Product Safety
BMW Recalls Over 105K Vehicles In U.S. Over Fire Risks Due To Overheating Starter Motor
August 08, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
BMWYY
YouthBio Therapeutics Announces Significant Results from Joint Study with Dr. Ocampo Demonstrating Amelioration of Age-Related Cognitive Decline
August 06, 2024
Via
PRLog
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Actuated Medical Developing Technology to Improve Targeting for Next-Generation Alcohol Use Disorder Treatments
August 06, 2024
Via
PRLog
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
Mental Health Watchdog Urges FDA to Ban Electroshock Device
August 05, 2024
Via
PRLog
Topics
Death
Lawsuit
Exposures
Death
Financial
Legal
3 Biotech Stocks With Promising Drug Pipelines: August 2024
August 08, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
BMY
BNTX
REGN
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Via
Benzinga
Exposures
Product Safety
Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results
August 07, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EXEL
Novo Nordisk Withdraws Wegovy FDA Heart Failure Submission, Terminates Development Of Two Early Stage Assets
August 07, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates
August 07, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Amgen's MariTide Weight Loss Potential: Stock Outlook
August 07, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
AMGN
LLY
NVO
XLV
Tesla Recalls 1.7M Vehicles In China Over Concerns Of Front Trunk Opening When Driving, After Recalling 1.8M Vehicles In US Over Similar Problems: To Fix Issue Via Over-The-Air Software Upgrade
August 07, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
JRE Offers Highly Durable Crimping Machines at Reasonable Rates
August 06, 2024
Via
Get News
Exposures
Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Submits New CNM-Au8 Biomarker, Clinical Efficacy Data to FDA
August 06, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Senators Press FDA To Approve MDMA As PTSD Treatment, Stressing US Vets' Suicide Rates As Aug 11 Decision Looms
August 06, 2024
Via
Benzinga
Exposures
Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call
August 06, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001 involving Patients with Bipolar Disorder and Alzheimer's Disease
August 06, 2024
Via
News Direct
Exposures
Product Safety
Tickers
ALZN
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ABBV
ALZN
ITCI
TEVA
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder and Alzheimer’s Disease
August 06, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
August 06, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ALZN
Headline
August 06, 2024
Via
News Direct
Exposures
Product Safety
Tickers
ALZN
Delegate to Elevate Transforms Entrepreneurial Success Stories Through Strategic Outsourcing
August 05, 2024
Via
Prodigy
Topics
Product Recall
Exposures
Legal
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Preparing for NDA Submission for Leading Drug Candidate
August 05, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PXMD
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
IXHL
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ATNM
FDA Panel Backs Zevra's Arimoclomol For Rare Genetic Disorder, Analyst Highlights Balanced Portfolio Of Marketed Products And Pipeline Assets Focused On Rare Diseases
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ZVRA
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ALZN
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.